Scott Wingerter, MD
Adult Reconstructive Orthopaedic Surgery · Leawood, KSNPI 1356549075
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,519 of the $4,519 with a category attached, or 77.9%. Stryker accounts for 60.3% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $1,375, 2.4 times the $577 reported in 2019.
Across 247 payments — averaging $18.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Applied Medical Resources Corporation$1K
- Amgen$437
- BD$164
- Linvatec Corporation$65
- Medtronic$50
- plus $79 from 3 others
What the payments were for
- Speaking & faculty fees$1,00022%
- Food & beverage$3,51978%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 198 | $2,724 |
| Applied Medical Resources Corporation | 1 | $1,000 |
| Amgen | 40 | $437 |
| BD | 1 | $164 |
| Linvatec Corporation | 1 | $65 |
| Medtronic | 2 | $50 |
| Zimmer Biomet | 2 | $45 |
| Bioventus LLC | 1 | $18 |
| Orthogenrx Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTA AH FLEXITIP$164
- MAKO$160
How this compares
Too few adult reconstructive orthopaedic surgery providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 285 | $4,155 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 53 | $556 |
| Celecoxib | 21 | $525 |
| Amoxicillin | 229 | $504 |
| Tramadol Hcl | 116 | $459 |
| Cephalexin | 14 | $391 |
| Ondansetron OdtOndansetron | 26 | $289 |
| Gabapentin | 32 | $230 |
| Clindamycin Hcl | 34 | $203 |
| Meloxicam | 73 | $167 |
| Cyclobenzaprine Hcl | 22 | $90 |
| Hydroxyzine Pamoate | 11 | $30 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Leawood
- Robert GardinerLeawood$391
- Tarun BhargavaWichita$534K
- Kelly HendricksOverland Park$250K
- Jonathon SalavaTopeka$52K
- Andrew PalmisanoOverland Park$40K
- Matthew de RuyterKansas City$23K
- Michael PerryOverland Park$14K
- Andrew MurthaKansas City$9K
- Paul PappademosWichita$4K
- Benjamin YoungWichita$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.